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Abstract  
Objectives: Widespread sensory deficits resembling hemihypoaesthesia occur in 20-40% of chronic pain 
patients on the side of pain, independent of pain aetiology, and have been termed nondermatomal sensory 
deficits (NDSD). Sensory profiles have rarely been investigated in NDSD.  
Methods: Quantitative sensory testing (QST) according to the protocol of the German Research Network on 
Neuropathic Pain (DFNS) was performed in the face, hand and foot of the painful body side and in 
contralateral regions in chronic pain patients. Twenty-five patients with NDSD and 23 without NDSD 
(termed pain-only group) were included after exclusion of neuropathic pain. Comprehensive clinical and 
psychiatric evaluations were done.  
Results: NDSD in chronic pain was associated with high burden of disease and more widespread pain. Only 
in the NDSD group significantly higher thresholds for mechanical and painful stimuli were found in at least 2 
of 3 regions ipsilateral to pain. In addition, we found a bilateral loss of function for temperature and vibration 
detection, and a gain of function for pressure pain in certain regions in patients with NDSD. Sensory loss and 
gain of function for pressure pain correlated with pain intensity in several regions. 
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Discussion: This may indicate a distinct sensory profile in chronic non-neuropathic pain and NDSD, 
probably attributable to altered central pain processing and sensitisation. The presence of NDSD in chronic 
non-neuropathic pain may be regarded as a marker for higher burden of pain disease. 
 
Key words: chronic pain; hemisensory loss; quantitative sensory testing; nondermatomal somatosensory 
deficits; sensitization 
Introduction  
Diagnostic workup of patients with chronic pain is important for pain classification and appropriate 
treatment. In patients with chronic pain and sensory abnormalities, neuropathic pain may be suspected and 
diagnostic work up according current diagnostic criteria is recommended [1]. Some of those patients will not 
meet the diagnostic criteria for neuropathic pain, the cause of sensory disturbances remaining unclear. It is 
known that 25 to 50% of the patients with chronic pain show widespread sensory deficits often resembling 
hemihypoaesthesia on the side of pain or worse pain [2, 3].  This phenomenon is termed nondermatomal 
somatosensory deficits (NDSD) [2, 3]. NDSD have been reported in various chronic non-neuropathic pain 
conditions including myofascial pain [2] and in complex regional pain syndrome (CRPS) [4]. The first 
description of this phenomenon dates back to the nineteen twenties [5]. It was considered to be “hysterical” 
or a sensory conversion disorder. Currently, NDSD are recognized as a neuro-psycho-biological condition [3, 
6] but cannot be fully explained by a psychiatric disorder [6, 7]. While no lesion of the central or peripheral 
nervous system has been identified, some functional abnormalities have been described in the literature. 
Functional MRI studies showed altered patterns of activation in response to sensory stimuli in somatosensory 
cortex and thalamus [8]. Recent neuroimaging studies identified also metabolic and structural changes in 
sensorimotor and temporal regions in patients with NDSD [7, 9].  The occurrence of NDSD in the absence of 
neurological cause has been suggested but not investigated systematically.  
Quantitative sensory testing (QST) has been developed to provide sensory profiles in reference regions [10-
12] and is widely used in research on chronic pain [13]. Sensory changes in painful regions and even beyond  
have been demonstrated in experimental pain, as in models of referred pain [14], heat-induced pain [15], or 
capsaicin induced pain [16], with a positive association between pain and sensory abnormalities, i.e. 
increased pain was associated with an increase in sensory changes [17]. In various chronic pain conditions 
sensory changes were demonstrated by QST, including the area of referred pain [18], bilateral regions in 
osteoarthritis [19], widespread regions in fibromyalgia [20, 21], areas within the affected segment in chronic 
back pain [21], outside of the pain area in chronic low back pain [22], myofascial temporomandibular joint 
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disorder [23, 24] and  chronic back pain [25-27]. However, hemihypoaesthesia in chronic pain verified using 
QST has been  reported only in complex regional pain syndrome [4]. A comprehensive systematical 
neurological work up in patients with NDSD and chronic pain including   neurophysiology studies and 
sensory profiling with QST is lacking.  
Therefore objectives of the study were (1) to describe prospectively clinical, neurophysiological and pain 
related aspects in patients with chronic non-neuropathic pain with and without NDSD; (2) to investigate 
whether the clinical findings of NDSD can be confirmed by QST; and (3) to compare QST profiles of chronic 
non-neuropathic pain patients with and without NDSD. Potential pathophysiological mechanisms will be 
discussed.  
Materials and Methods 
Patient recruitment 
The study cohort was the same as in a previous study [7] and will described in brief. Local ethics committee 
approvals were obtained. Patients were recruited from  the Centre for Pain Medicine, Nottwil,  the Headache 
& Pain Unit, University Hospital Zurich and the Psychosomatic Division, University Hospital Berne. All 
patients were evaluated in a multidisciplinary setting involving psychiatrists, psychologists, neurologists, 
rheumatologists and orthopaedists. Eligible patients were included after informed consent. Inclusion criteria 
were the following: Age between 20 and 65 years, sufficient understanding of German language, pain 
duration for more than six months, normal neurological examination except for the presence of a 
reproducible unilateral sensory deficit in the NDSD group (including upper and lower extremities and trunk 
with possible involvement of the face), normal sensation in the pain-only group, normal neurophysiology 
results (nerve conduction studies and somatosensory evoked potentials of tibial nerves) and normal MRI of 
the brain. Exclusion criteria were the following: Any neurological disease other than pain, inflammatory 
rheumatologic disorder, severe psychiatric disorders requiring psychiatric hospitalisation or associated with 
suicidality at any time. The inclusion procedure and all study related investigations were performed at the 
Centre for Pain Medicine Nottwil. For a rough estimate of the prevalence of NDSD in one study center 
(Nottwil) a database research was performed retrospectively, searching for patients with chronic pain and 
sensory deficits. 
Pain evaluation and psychological comorbidity 
A standardized pain history was obtained using the validated pain questionnaire of the German Society for 
the Study of Pain [28], including pain drawings. Anxiety and depression were assessed using the Hospital 
Anxiety and Depression Scale (HADS [29]). Health-related quality of life was determined by the SF-12 
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questionnaire [30]. Chronic pain severity was assessed using the Graded Chronic Pain Scale (GCPS) [31]. 
The grade of pain chronification was defined by the Mainz Pain Staging System (MPSS) [32]. This is a 
questionnaire consisting of 11 items (on pain characteristics, types of medication used, previous consultations 
of physicians, pain related interventions and hospital admissions, and participation in rehabilitation 
programmes) to assign the pain into one of three possible stages of disease chronification, which has been 
validated in several studies [33, 34]. From the pain drawings the number of affected body areas by pain (n 
out of 53) were counted according the areas (right, midline and left body) described elsewhere [35]. 
Clinical examination 
In all patients a comprehensive neurological examination was performed focussing on the sensory system 
(aesthesia, thermaesthesia and algesia), by two experienced neurologists (G.L. and F.R.) independently at 
different time points. 
Aesthesia was assessed with a standardized brush with a force of about 200-400mN (Brush 05, Senselab
R
, 
Sweden), thermaesthesia with a cold roller (stainless steel, width 35mm, diameter 25mm, resting between 
investigations on a 100x40x5mm stainless steel plate to keep the temperature constant at room air about 
22°C) and algesia to pinprick with a validated 40g weighted pinprick (Neuropen
R
, Owen Mumford, UK). The 
investigation of vibration sense was performed within the QST protocol (see below). We defined 80 body 
areas throughout the whole body, ventrally and dorsally, where all 3 qualities were tested. The report of 
diminished sensation after side to side comparison by the patient was drawn in body figures for each quality 
in separate drawings.  
Neurophysiological examination and imaging 
All patients underwent a neurophysiological examination in a quiet air conditioned room with constant room 
temperature of 22.0-23.0°C. Nerve conduction studies (NCS) were performed for median and tibial nerves on 
the ipsilateral side (see below) and for sural nerves on both sides. Motor NCS (median and tibial nerves) 
included motor nerve conduction velocity, motor amplitudes and F-wave studies. Sensory NCS (median and 
sural nerves) included sensory nerve conduction velocity and sensory amplitudes. In addition, somatosensory 
evoked potentials (SEP) of tibial nerves on both sides were obtained including latency P40 and amplitude 
P40/N45. A neurophysiology machine type VikingSelect, software VikingSelect Master Software version 11 
by Nicolet, Biomedical, USA, was used. Patients with any abnormalities indicating impaired peripheral of 
central neuronal conduction were excluded from the study. Procedures and normal values were used as 
described in the literature for NCS [36] and SEP [37].  
Thermography 
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Infrared thermography was performed under room conditions described as above, after the patient had 
adapted to room conditions for 15min resting in a supine position. An infrared thermo camera ThermaCam
TM
 
E4 (Flir Systems, USA), was used. Thermographs were taken perpendicular to the body surface with a 
camera-body-distance of 100cm for the face and 50cm for the hands and feet. Thermographs were analysed 
using the software ThermaCam Researcher 2.7 professional, Flir Systems, USA, setting reference points in 
defined areas. In the face single reference points were set in a vertical line bilaterally within the 1
st
, 2
nd
 and 
3
rd
 trigeminal nerve division. At the hand reference points were set at the dorsum of the hand and dorsum of 
the distal phalanx of the 1
st
, 3
rd
 and 5
th
 finger (representing the dermatomes C6, C7 and C8) as well as on the 
dorsum of the feet and dorsum of distal phalanx of 1
st
 and 5
th
 toe (representing the dermatomes L5 and S1). 
Temperature was recorded in Celsius degrees (°C). According to the literature [38] a side to side difference 
of at least 1°C was considered abnormal.  
Quantitative sensory testing 
QST was performed according the standardized protocol developed by the German Research Network on 
Neuropathic Pain (DFNS) [10]. Room conditions were as described above. All tests were performed by the 
same medical technician (L.S.) who underwent a training program certified by DFNS. The tests were 
performed bilaterally in the face (cheek), dorsum of hand and dorsum of foot. For thermal parameters, a 
standardized diagnostic device (TSA-II, Medoc, Israel, temperature range: 0–50 °C, baseline temperature 32 
°C) with a 9.0 cm
2
 contact surface of the thermode and related computer software (version 5.35) was used. 
Thermal tests were performed, including cold detection threshold (CDT), warm detection threshold (WDT), 
cold pain threshold (CPT) and heat pain threshold (HPT). The mechanical testing included the mechanical 
detection threshold (MDT), using a standardized set of modified von Frey hairs (Opti-hair2-Set, Marstock 
Nervtest, Germany) and the mechanical pain threshold (MPT) using calibrated pinpricks (MRC Systems, 
Heidelberg, Germany). The vibration detection threshold (VDT) was examined using a Rydel-Seiffer tuning 
fork (64 Hz) which was applied over prominent bones, which is for the face the Zygomatic process, for hand 
the Ulnar styloid process and for foot the medial malleolus. The pressure pain threshold (PPT) is measured 
over muscles. For the face pressure algometer (FDN100, Wagner Instruments, Greenwich, USA) was applied 
over the masseter muscle. For hand and foot pressure algometer (FDN200, Wagner Instruments, Greenwich, 
USA) was applied over thenar eminence and abductor hallucis muscle respectively.  
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Statistics  
Clinical data were analysed with IBM SPSS Statistics (version 20, Armonk, NY: IBM Corp.). Independent 
samples t-tests were used to compare normally distributed data, Mann-Whitney U-tests for non-normally 
distributed continuous and ordinal data. Chi-square or Fisher´s exact tests were used to compare categorical 
data between groups. In accordance with the DFNS protocol [10], all QST values except CPT, HPT, and 
VDT were log transformed to achieve normal distribution. QST-parameters were z-transformed before 
analysis, based on age and gender specific reference data for each test site from the literature, according to 
the formula:  Z-score = (X single patient – Mean controls) / SD controls) [10]. In the NDSD group “ipsilateral” was the 
side of pain or worse pain, which was in accordance with the side of sensory deficits of the clinical 
examination, except one patient where sensory deficits were found at the opposite site to the worse pain site. 
In this patient the side of sensory deficit was chosen as ipsilateral. In the pain-only group “ipsilateral” was 
assigned to the side of pain, worse pain or based on randomisation if there was no pronounced pain side. A 
repeated measures ANOVA with the between subjects factor “group” (NDSD group and pain-only group) 
and the within subject factor “side” (ipsilateral–contralateral) was performed. As post-hoc tests, independent 
samples t-tests were performed to compare parameters between the NDSD and pain-only groups on ipsi- and 
contraleral sides, respectively, considering all p≤0.003 as statistically significant (after Bonferroni 
correction). In addition, side to side comparisons were performed using paired t-tests in each patient group. 
The Bonferroni-Holm procedure was used to correct for multiple comparisons, analyzing 8 QST-parameters 
[39]. 
Finally, possible relations between ipsilateral sensory loss and pain intensity as well as anxiety were 
investigated using Spearman`s correlations. These analyses included patients with NDSD and “pain-only”. 
The Bonferroni-Holm procedure was used to correct for multiple comparisons, as described above. 
Results 
Patient selection, socio-demographic data, pain related data and psychological comorbidity 
For details of the selection procedure we refer to figure Supplemental Digital Content 
1.,http://links.lww.com/CJP/A383  Seventy five patients were contacted for the NDSD group and 77 patients 
for group “pain-only” based on electronic chart records.  Finally, 25 patients could be included in the NDSD 
group and 23 patients in the pain-only group. The Nottwil databank request revealed 107 patients with 
hemisensory deficits among 2995 unselected consecutive patients (including neuropathic pain, chronic non-
neuropathic pain or chronic non-neuropathic pain with neurological comorbidity) during a 4 year time period 
(2007 to 2010) which equals a prevalence of 3,6%.  
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Socio-demographic data and pain related data and psychological variables are shown in Table 1. A full 
description of the psychological evaluation has been published elsewhere [7].  Age and gender were not 
significantly different between groups. The NDSD group showed significantly more frequently migration 
background, predominantly from south-eastern Europe, higher pain chronicity, had higher grades of pain 
severity, lower physical health related quality of life and higher anxiety scores. The main pain diagnoses 
based on comprehensive multidisciplinary assessment were the following (NDSD/pain-only): Headache 
(6/0), neck and upper extremity pain of different etiologies (non-specific 6/6, myofascial 3/0, facetogenic 
0/4), back and lower extremity pain of different etiologies (non-specific 4/4, myofascial 2/3, facetogenic 0/5), 
non-specific abdominal pain (1/0), fibromyalgia (1/1) and non-specific hemibody pain (2/0). In addition to 
the main pain diagnosis most patients had multiple additional pain locations. More detailed main pain 
diagnoses, distributions of all pain areas and NDSD localizations are shown in table Supplemental Digital 
Content 2, http://links.lww.com/CJP/A384  for the NDSD group. For the pain only group detailed data 
related to pain diagnoses and pain location are shown in table Supplemental Digital Content 3., 
http://links.lww.com/CJP/A385  In the NDSD group significantly more body areas were affected by pain in 
comparison to the pain-only group (37,3%±15,4 vs. 24%±18,5%, p=0,010).   
An exception of this observation is one patient with headache only (N37 with trigemino-autonomic 
headache) who had pronounced hemisensory deficits for all qualities.  
Clinical findings of somatosensory disturbances 
The neurological examination was unremarkable except for hemibody sensory changes in the NDSD group 
which were found on the right side in 15 patients and on the left side in 10 patients. In the NDSD group 2 
patients had a full hemibody sensory deficit for all modalities at the side of worse pain (patient N11 and 
N27), 22 had incomplete hemisensory deficits for all qualities at the side of worse pain, whereas one patient 
had an incomplete diminished hemibody sensation for all qualities at the less affected pain side (patient N35). 
Eleven patients had diminished sensation in a hemibody distribution only on side of pain or worse pain, 
whereas 11 patients had additional few areas of diminished sensation on the contralateral side. The 
percentage of affected areas with hypoaesthesia correlated positively with the percentage of regions with 
thermhypoaesthesia (Spearman´s rho=0.76; p<0.001) and pinprick hypoalgesia (Spearman´s rho=0.76; 
p<0.001). In 8 patients of the NDSD group the amount of body areas affected by NDSD was clearly more 
extensive than the amount of body areas affected by pain (patient N03, N13, N21, N24, N27, N30, N35, 
N37), see table Supplemental Digital Content 2., http://links.lww.com/CJP/A384  
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Neurophysiology and thermography 
Neurophysiology and thermography studies in both groups were within normal limits and without significant 
side to side differences. 
Figure 1 to be placed here 
Quantitative sensory testing 
Group and side differences  
Increases in sensory threshold are related to loss of sensory function, and are shown with negative z-scores in 
Fig.1. CDT was significantly higher in the NDSD group compared to the pain-only group in all 3 regions 
investigated (Table 2). The significant interaction “group” x “side” for the region face is consistent with 
higher ipsilateral (as compared to contralateral) CDT only in the NDSD group. This was confirmed by direct 
side to side comparisons. Post-hoc tests showed that patients in the NDSD group had increased CDT 
compared to those in the pain-only group on ipsi- and contralateral sides in the region face, i.e. patients with 
NDSD had bilateral sensory loss in the face (Fig. 1). WDT was significantly higher in the NDSD group 
compared to the pain-only group in the region face but not in the regions hand and foot (confirmed by side to 
side comparisons). Post-hoc tests revealed bilaterally increased WDT in the NDSD group compared to the 
pain-only group in the face. Side to side comparisons revealed increased ipsilateral compared to contralateral 
WDT in the face only in NDSD patients. For CPT and HPT a significant interaction “group” x “side” in the 
region foot was found indicating a significant increase ipsilateral compared to contralateral CPT and HPT 
only in the NDSD group  (confirmed by side to side comparisons). MDT was significantly higher in the 
NDSD group compared to pain-only group in all 3 regions investigated. The significant interaction “group” x 
“side” for all 3 regions is consistent with higher ipsilateral (as compared to contralateral) MDT in all regions 
only in the NDSD group (confirmed by side to side comparisons). MPT was significantly increased in the 
NDSD group in hand and foot, only on ipsilateral sides according to post-hoc tests. Side to side comparisons 
detected increased MPT on the ipsilateral compared to contralateral side in the face and feet only in the 
NDSD group. VDT was significantly increased in the NDSD group in all 3 regions investigated. Post-hoc 
tests revealed bilateral VDT increases in the NDSD group compared to the pain-only group for all 3 regions 
investigated. PPT was significantly decreased in the regions hand and foot in the NDSD group. Post-hoc 
tests showed decreased PPT in the NDSD group compared to the pain-only group in the region foot on the 
contralateral side, while direct side to side differences showed no significant differences. 
Summary of side to side differences 
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Sensory profiles using z-transformation of both groups are summarized in Fig. 1. Sensory thresholds in 
original values before z-transformation are given in table Supplemental Digital Content 4, 
http://links.lww.com/CJP/A386  for the NDSD group and in table Supplemental Digital Content 5, 
http://links.lww.com/CJP/A387  for the pain-only group. Patients in the NDSD group showed a significant 
increase for several thresholds on the side ipsilateral to pain:  MDT was significantly increased in all 3 
regions (face, p=0.003; hand p=0.001; foot; p=0.001). MPT was significantly increased in 2 regions (face, 
p=0.005; foot, p=0.035). Increases in one region were found for HPT (p=0.002) and CPT (p=0.002) in foot, 
CDT (p=0.007) and WDT (p=0.009) in the face. Side differences were more pronounced in the regions face 
and foot as compared to hands. Patients in the pain-only group did not show significant side to side 
differences for any parameters investigated.  
Correlation of sensory thresholds on ipsilateral sides with pain intensity and anxiety 
Pain intensity was associated with loss of sensory function (negative z-scores) as opposed to a gain of 
function for pressure pain (positive z-scores), as summarized in Fig. 2. Pain intensity correlated negatively 
with z-scores for VDT (face, hand), CDT (face), MDT (hand) and positively with z-scores for PPT (face, 
hand). Anxiety was associated with losses of sensory function. Anxiety (HADS-A score) correlated 
negatively with z-scores for CDT (face), WDT (face) and VDT (face, hand, foot) (Fig. 3). 
Figures 2 and figure 3 to be placed here. 
 
Discussion 
The main findings of present study were the following:  
(1) The phenomenon of NDSD in chronic pain is associated with high burden of disease and more 
widespread pain.  
(2) Changes in sensory function in patients with NDSD can be objectified by quantitative sensory testing: In 
the NDSD group significantly higher thresholds for mechanical and painful stimuli were found ipsilaterally 
to pain. Sensory loss correlated with pain intensity in several regions. Importantly, all patients had normal 
neurophysiology studies. 
(3) In addition to lateralised sensory loss, we found general alterations in sensory function in patients with 
NDSD: These include a bilateral loss of function for temperature and vibration detection, as well as a gain of 
function for pressure pain in certain regions. The latter correlated positively with pain intensity. 
Demography, pain characteristis and comorbidity 
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The NDSD cohort was comparable to previous studies, concerning demographic data [2, 6, 9]. Our findings 
of more frequent migration background, higher pain chronicity, higher grades of pain severity, lower physical 
health related quality of life, and as previously published, higher pain intensity, higher anxiety scores and 
prevalence of absenteeism from work [7] in the NDSD group in comparison to the pain-only group indicate a 
higher burden of pain disease. Consistent with these findings, higher pain intensities and disease related 
impairment in patients with NDSD have been reported in various studies [2, 3, 6, 40]. In our NDSD group, a 
relatively large proportion had migrated from south east Europe. It could be speculated that they might have 
experienced particularly stressful life events in war-torn countries, as NDSD has been related to traumatic life 
events previously [6]. In our patients with NDSD, traumatic life event or a diagnosis of PTSD seemed 
slightly overrepresented, but this was not significant [7]. The estimated NDSD prevalence of 3.6% at one 
study centre (Nottwil) was very low compared to previous studies that found a prevalence between 17 and 
38% [2, 41, 42] in certain chronic pain cohorts. This may be related to sample characteristics such as a wide 
variety of different chronic pain diagnoses treated at the Nottwil centre. Since the inclusion criterion to the 
study was a hemisensory deficit, a wide variety of chronic non-neuropathic pain syndromes was included. 
Accordingly, NDSD have been reported in several chronic non-neuropathic pain conditions [2-4, 41-43] but 
extension of painful regions has not been described. Therefore our finding of more extensive pain sites in the 
NDSD group suggests that NDSD are observed particularly in widespread pain syndromes. As an exception 
of this observation we found NDSD in one patient who had one-sided headache as the only pain location.  
Neurophysiology, thermography and neuroimaging 
The present cohort was investigated with prospective neurophysiology studies and brain imaging [7] to rule 
out gross functional abnormalities and structural pathology. Normal neurophysiology and imaging of the 
nervous system have been reported in chronic pain patients with NDSD based on chart reviews, but have not 
been systematically studied in previous studies [2, 6, 9].  In contrast, in CRPS with NDSD, several 
abnormalities in NCS, SEP and sympathetic skin response were found, suggesting different underlying or 
concomitant pathology in the case of CRPS [4]. In the literature NDSD have occasionally been described in 
radiculopathy with SEP and MRI abnormalities [44]. Our study demonstrates that NDSD can be observed in 
patients with chronic non-neuropathic pain syndromes in absence of neurophysiological abnormalities. 
Normal infrared thermography in our groups suggests lack of involvement of the vasomotor system. In 
contrast, the appearance of NDSD in context of an injury of the sympathetic nervous system, has been 
suggested in the past [45]. 
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 Clinical somatosensory findings and QST 
In our cohort, diminished sensation in a hemibody distribution on the side of pain or worse pain was present 
in nearly all patients with NDSD, although one patient with frequent migraine had NDSD at the less 
pronounced pain side. In addition, about half of the patients with NDSD had additional spots of diminished 
sensation opposite to the pain side. In rare cases, NDSD has been described  occur on the side opposite to 
pain [3].  
In the clinical examination, we found abnormalities for aesthesia, algesia and thermaesthesia to be associated 
with each other, suggesting that these abnormalities are frequently observed together and should be examined 
in daily practice. This observation was reflected in QST were loss of function was found for MDT in 3, for 
MPT in 2, and for CDT, WDT, CPT, HPT in one test region ipsilateral to pain. Thus, significant side to side 
differences were not found for all parameters in every region. This may be explained by the following 
reasons: (1) incomplete expression of NDSD in some patients and (2) wide variations in the extent of pain 
distribution at the most affected side and at the opposite side (3) some patients showed minor negative signs 
at the opposite side in the clinical examination, and bilateral sensory changes in QST as outlined below. (4) 
The extensive QST protocol could only be performed in reference regions.  
Widespread sensory abnormalities in NDSD involve small fibre and thick myelinated fibre function in the 
periphery, as well as spinothalamic and dorsal column pathways centrally at spinal cord level. This suggests 
the involvement of supraspinal rather than spinal mechanisms within the CNS which is consistent with 
neuroimaging studies discussed below.  As sensory aspects of pain and sensory perception are mediated by 
the lateral pain system including thalamus, insular cortex and somatosensory cortex [46], chronic pain input 
from the same body side may interfere with sensory processing and modulate respectively suppress sensory 
perception. Previously, it has been hypothesized previously that NDSDs may result from an attempt of the 
brain to shut down all input from painful regions which is however insufficient for adequate pain control but 
causes sensory loss for various sensory abnormalities [8]. Consistent with this idea, sensory loss correlated 
with pain intensity in several regions in the present study. Reduced perception for sensory or painful stimuli 
was associated with deactivation or lack of activation in contralateral primary and secondary somatosensory 
cortex, and a lack of activation in the contralateral thalamus [8, 47] in fMRI studies.   
Functional and structural neuroimaging studies [7-9] showed also bilateral alterations in NDSD, which could 
relate to the bilateral sensory abnormalities for vibration and temperature sensation, found in the present 
study. A PET study in NDSD patients showed significant hypometabolic pattern of changes in cortical and 
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subcortical areas bilateral [9] involving limbic regions. Dysfunctional sensory processing in patients with 
NDSD is associated with complex bilateral changes in grey matter volume, including the somatosensory 
system and temporal regions involved in multisensory integration [7].    
The gain of function for pressure pain, which correlated with pain intensity, increased sensitivity to gentle 
palpation in the area of sensory deficits [3] and the observation of more widespread pain in NDSD can be 
interpreted as signs of central sensitisation. In this condition an increased responsiveness of neurons to their 
normal input occurs due to a drop in sensory thresholds probably involving a dysfunction of the endogenous 
pain control systems at brainstem level [48, 49]. It could be assumed that the spreading of pain is a clinical 
manifestation of central sensitization that has occurred in chronic pain patients under stressful conditions, as 
seen in various chronic pain syndromes [50]. We hypothesize that NDSD may also result from maladaptive 
central mechanisms trying to counteract central sensitization that has already occurred in a chronic pain 
population, which are however insufficient to control pain but cause widespread hypoesthesia for several 
sensory modalities. This may involve descending inhibitory mechanisms at the level of the brainstem. 
 Intriguingly, bilateral localized sensory loss has been reported in experimental pain models [14] and in 
localized chronic pain [18, 19, 22]. In addition, increased local sensitivity to pressure pain has been 
consistently reported in chronic non-neuropathic pain patients [18, 51, 52] in combination with additional 
negative signs.  
The correlation of anxiety with sensory loss for thermal and vibration sense may be an example how psycho-
social stress may interact with sensory processing in chronic pain. This may be mediated by the medial pain 
system where motivational-affective factors interact with pain perception [49]. Afferent projections to this 
area have been demonstrated [53].  
 Considering studies on fibromyalgia, reporting evidence of small fiber neuropathy based on QST findings 
and skin biopsy, it could be discussed whether the observed sensory changes may be related to small fiber 
neuropathy, which cannot be ruled out by normal nerve conduction studies [54]. However, sensory profiles 
with unilateral and bilateral alterations, involving also gain of function for pressure pain, with pronounced 
changes also in the face are not suggestive for localized distal small fiber neuropathy. Rather, involvement of 
different sensory modalities points towards central dysfunction.   
To our knowledge QST has not been studied systematically in patients with chronic non-neuropathic pain 
with NDSD. QST-data have been reported in patients with CRPS I and II and NDSD [4] showing 
significantly increased thresholds to touch, warm, and cold sensation as well as for heat pain in five tested 
regions at the side of CRPS.  
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
Limitations of the study  
Although QST has been validated in several clinical trials and has been shown to provide reproducible results 
[55], it remains a psychophysical method, dependent on the patient´s attention and compliance.  
QST as a time consuming method could only be applied in selected body areas as face, hand and foot 
bilaterally in this study. Effort was made to demonstrate extensive sensory changes beyond the pain area. In 
the present study, QST was not done within the area of pain maximum. Therefore, our results were not 
comparable to most studies investigating sensory pain profiling within the pain maximum. Finally, vibration 
sense was not included into the extensive screening procedure based on aesthesia, thermaesthesia and algesia. 
Thus it cannot be fully excluded that bilateral loss in VDT was observed because unilateral loss in vibration 
sense was not an inclusion criterion. However, bilateral changes were also found for modalities included in 
the screening procedure such as CDT and WDT.  
Clinical perspective and conclusion  
Pain phenotyping recently becomes a major field in research to improve patients` response to treatment [56]. 
For psychological phenotyping the HADS and for sensory phenotyping the DFNS QST battery are 
recommended [56]. We showed a correlation of psychological phenotype markers such as anxiety and pain 
intensity with several QST parameters.  
The association of affective disturbances and chronic pain is widely recognised [57]. Psychosocial 
phenotyping in our study revealed that the occurrence of NDSD in chronic pain patients is associated with 
more extensive pain sites, higher ratings for anxiety, lower physical quality of life, higher grades of pain 
severity and chronicity and higher prevalence of migration background. NDSD may be regarded as a pain 
phenotype expressing a higher burden of pain disease.  
The combination loss of function for thermal and mechanical modalities and gain of function for mechanical 
pressure pain as a sign of sensitization in NDSD may have impact on the management of patients with 
chronic non-neuropathic pain. Further studies are indicated with focus on QST in chronic non-neuropathic 
pain with or without NDSD to evaluate conceptions of pain phenotyping and treatment response.  
 
  
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
Acknowledgements:  
This work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung (FWF; Austria): 
Erwin-Schrödinger  Stipend to Franz Riederer. The authors would like to thank all patients who were willing 
to participate in the study. We are grateful for valuable comments by the reviewers.  
References 
1. Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, 
Hughes R, Nurmikko T and Serra J. Neuropathic pain: Redefinition and a grading system for 
clinical and research purposes. Neurology 2008;70:1630-1635. 
2. Mailis A, Papagapiou M, Umana M, Cohodarevic T, Nowak J and Nicholson K. Unexplainable 
nondermatomal somatosensory deficits in patients with chronic nonmalignant pain in the context of 
litigation/compensation: a role for involvement of central factors? The Journal of Rheumatology 
2001;28:1385-1393. 
3. Mailis-Gagnon A and Nicholson K. On the Nature of Nondermatomal Somatosensory Deficits. 
The Clinical journal of pain 2011;27:76-84. 
4. Rommel O, Malin J-P, Zenz M and Jänig W. Quantitative sensory testing, neurophysiological 
and psychological examination in patients with complex regional pain syndrome and hemisensory 
deficits. Pain 2001;93:279-293. 
5. Pette H. Das Problem der wechselseitigen Beziehung zwischen Sympathikus und Sensibilität. 
Dtsch Z Nervenheilkd 1927;100:143–148. 
6. Egloff N, Maecker F, Stauber S, Sabbioni ME, Tunklova L and von Kanel R. Nondermatomal 
somatosensory deficits in chronic pain patients: are they really hysterical? Pain 2012;153:1847-51. 
7. Riederer F, Landmann G, Gantenbein AR, Stockinger L, Egloff N, Sprott H, Schleinzer W, 
Pirrotta R, Dumat W, Luechinger R, Baumgartner C, Kollias S and Sandor PS. Nondermatomal 
somatosensory deficits in chronic pain are associated with cerebral grey matter changes. The world 
journal of biological psychiatry : the official journal of the World Federation of Societies of 
Biological Psychiatry 2015:1-12. 
8. Mailis-Gagnon A, Giannoylis I, Downar J, Kwan CL, Mikulis DJ, Crawley AP, Nicholson K and 
Davis KD. Altered central somatosensory processing in chronic pain patients with “hysterical” 
anesthesia. Neurology 2003;60:1501-1507. 
9. Egloff N, Sabbioni ME, Salathe C, Wiest R and Juengling FD. Nondermatomal somatosensory 
deficits in patients with chronic pain disorder: clinical findings and hypometabolic pattern in FDG-
PET. Pain 2009;145:252-8. 
10. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein 
F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, 
Rolko C, Schaub C, Scherens A, Sprenger T, Valet M and Wasserka B. Quantitative sensory 
testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and 
reference values. Pain 2006;123:231-243. 
11. Magerl W, Krumova EK, Baron R, Tolle T, Treede RD and Maier C. Reference data for 
quantitative sensory testing (QST): refined stratification for age and a novel method for statistical 
comparison of group data. Pain 2010;151:598-605. 
12. Pfau DB, Krumova EK, Treede RD, Baron R, Toelle T, Birklein F, Eich W, Geber C, Gerhardt 
A, Weiss T, Magerl W and Maier C. Quantitative sensory testing in the German Research Network 
on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic 
postherpetic neuralgia. Pain 2014;155:1002-15. 
13. Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman 
R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, 
Rice AS, Rolke R, Treede R-D, Serra J, Toelle T, Tugnoli V, Walk D, Walalce MS, Ware M, 
Yarnitsky D and Ziegler D. Value of quantitative sensory testing in neurological and pain 
disorders: NeuPSIG consensus. PAIN 2013;154:1807-1819. 
14. Leffler AS, Kosek E and Hansson P. Injection of hypertonic saline into musculus infraspinatus 
resulted in referred pain and sensory disturbances in the ipsilateral upper arm. European journal of 
pain 2000;4:73-82. 
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
15. Apkarian AV, Stea RA and Bolanowski SJ. Heat-induced pain diminishes vibrotactile 
perception: a touch gate. Somatosens Mot Res 1994;11:259-67. 
16. Magerl W and Treede RD. Secondary tactile hypoesthesia: a novel type of pain-induced 
somatosensory plasticity in human subjects. Neuroscience letters 2004;361:136-9. 
17. Leffler AS, Kosek E and Hansson P. The influence of pain intensity on somatosensory 
perception in patients suffering from subacute/chronic lateral epicondylalgia. European journal of 
pain 2000;4:57-71. 
18. Leffler AS, Hansson P and Kosek E. Somatosensory perception in patients suffering from long-
term trapezius myalgia at the site overlying the most painful part of the muscle and in an area of 
pain referral. European journal of pain 2003;7:267-76. 
19. Westermann A, Rönnau A-K, Krumova E, Regeniter S, Schwenkreis P, Rolke R, Treede R-D, 
Richter H and Maier C. Pain-associated Mild Sensory Deficits Without Hyperalgesia in Chronic 
Non-neuropathic Pain. The Clinical journal of pain 2011;27:782-789. 
20. Tampin B, Slater H, Hall T, Lee G and Briffa NK. Quantitative sensory testing somatosensory 
profiles in patients with cervical radiculopathy are distinct from those in patients with nonspecific 
neck-arm pain. Pain 2012;153:2403-14. 
21. Blumenstiel K, Gerhardt A, Rolke R, Bieber C, Tesarz J, Friederich H-C, Eich W and Treede 
R-D. Quantitative Sensory Testing Profiles in Chronic Back Pain Are Distinct From Those in 
Fibromyalgia. The Clinical journal of pain 2011;27:682-690. 
22. Freynhagen R, Rolke R, Baron R, Tolle TR, Rutjes AK, Schu S and Treede RD. 
Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? 
Answers from quantitative sensory testing. Pain 2008;135:65-74. 
23. Fernandez-de-las-Penas C, Galan-del-Rio F, Fernandez-Carnero J, Pesquera J, Arendt-Nielsen 
L and Svensson P. Bilateral widespread mechanical pain sensitivity in women with myofascial 
temporomandibular disorder: evidence of impairment in central nociceptive processing. The 
journal of pain : official journal of the American Pain Society 2009;10:1170-8. 
24. Pfau DB, Rolke R, Nickel R, Treede RD and Daublaender M. Somatosensory profiles in 
subgroups of patients with myogenic temporomandibular disorders and Fibromyalgia Syndrome. 
Pain 2009;147:72-83. 
25. Clauw DJ, Williams D, Lauerman W, Dahlman M, Aslami A, Nachemson AL, Kobrine AI and 
Wiesel SW. Pain Sensitivity as a Correlate of Clinical Status in Individuals With Chronic Low 
Back Pain. Spine 1999;21:2035. 
26. George SZ, Wittmer VT, Fillingim RB and Robinson ME. Sex and pain-related psychological 
variables are associated with thermal pain sensitivity for patients with chronic low back pain. The 
journal of pain : official journal of the American Pain Society 2007;8:2-10. 
27. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA and Clauw DJ. 
Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis and 
rheumatism 2004;50:613-23. 
28. Nagel B, Gerbershagen H, Lindena G and Pfingsten M. Development and evaluation of the 
multidimensional German pain questionnaire. Schmerz 2002;16:263-270. 
29. Zigmond AS and Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 
1983;67:361-70. 
30. Ware J, Jr., Kosinski M and Keller SD. A 12-Item Short-Form Health Survey: construction of 
scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33. 
31. Von Korff M, Ormel J, Keefe FJ and Dworkin SF. Grading the severity of chronic pain. Pain 
1992;50:133-49. 
32. Gerbershagen U. [Organized treatment of pain. Determination of status]. Internist (Berl) 
1986;27:459-69. 
33. Huppe M, Maier C, Gockel H, Zenz M and Frettloh J. [Success of treatment in higher stages of 
pain chronification as well? An evaluation of the Mainz pain staging system based on the QUAST-
analysis sample]. Schmerz 2011;25:77-88. 
34. Frettloh J, Maier C, Gockel H and Huppe M. [Validation of the German Mainz Pain Staging 
System in different pain syndromes]. Schmerz 2003;17:240-51. 
35. Widerstrom-Noga E, Biering-Sorensen F, Bryce T, Cardenas DD, Finnerup NB, Jensen MP, 
Richards JS and Siddall PJ. The international spinal cord injury pain basic data set. Spinal Cord 
2008;46:818-23. 
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
36. Bischoff C, Schulte-Mattler W and Conrad B. Das EMG Buch. Stuttgart: Georg Thieme Verlag 
Stuttgart, 2005. 
37. Riffel B, M S and S K. Spinal and cortical evoked potentials following stimulation of the 
posterior tibial nerve in the diagnosis and localization of spinal cord diseases. Electroencephalogr 
Clin Neurophysiol 1984;58:400-7. 
38. Feldman F. Thermography of the hand and wrist: practical applications. Hand clinics 
1991;7:99-112. 
39. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of 
Statistics 1979;6:65–70. 
40. Fishbain DA, Cutler RB, Lewis J, Cole B, Rosomoff RS and Rosomoff HL. Is the Location of 
Nondermatomal Sensory Abnormalities (NDSAs) Related to Pain Location? Pain medicine 
2003;4:238-243. 
41. Rommel O, Gehling M, Dertwinkel R, Witscher K, Zenz M, Malin JP and Janig W. 
Hemisensory impairment in patients with complex regional pain syndrome. Pain 1999;80:95-101. 
42. da Silva LA, Kazyiama HH, Teixeira MJ and de Siqueira SR. Quantitative sensory testing in 
fibromyalgia and hemisensory syndrome: comparison with controls. Rheumatol Int 2013;33:2009-
17. 
43. Rommel O, Malin JP, Janig W, Zenz M, Rommel O, Malin JP, Janig W and Zenz M. [Clinical 
findings in patients with chronic complex regional pain syndrome]. Anaesthesist 2004;53:965-77. 
44. Rommel O, Maercklin A, Eichbaum A, Kuprian A and Jäger G. Hemisensorische Störungen 
bei neuropathischen Schmerzen im Rahmen chronischer Nervenwurzelreizsyndrome. Der Schmerz 
2005;19:59-64. 
45. Gross D Gefaesszone und Quadrant. Therapeutische Leitungsnaesthesie. Stuttgart: Thieme, 
1982. 
46. Treede RD, Kenshalo DR, Gracely RH and Jones AK. The cortical representation of pain. Pain 
1999;79:105-11. 
47. Egloff N, Gander ML, Gerber S, von Kanel R and Wiest R. [Chronic right-sided pain-
associated nondermatomal somatosensory deficit following an accident]. Praxis 2010;99:797-801. 
48. Loeser JD and Treede RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain 
2008;137:473-7. 
49. Westlund K. Pain Pathways: Peripheral, Spinal, Ascending, and Descending Pathways. 
Philadelphia: Elsevier Mosby, 2014. 
50. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 
2011;152:S2-15. 
51. Kavchak AJE, Fernández-de-las-Peñas C, Rubin LH, Arendt-Nielsen L, Chmell SJ, Durr RK 
and Courtney CA. Association Between Altered Somatosensation, Pain, and Knee Stability in 
Patients With Severe Knee Osteoarthrosis. The Clinical journal of pain 2012;28:589-594. 
52. Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B, Wylde V, Arendt-Nielsen L 
and Zhang W. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-
analysis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2012;20:1075-85. 
53. Wang CC and Shyu BC. Differential projections from the mediodorsal and centrolateral 
thalamic nuclei to the frontal cortex in rats. Brain Res 2004;995:226-35. 
54. Üçeyler N, Zeller D, Kahn A-K, Kewenig S, Kittel-Schneider S, Schmid A, Casanova-Molla J, 
Reiners K and Sommer C. Small fibre pathology in patients with fibromyalgia syndrome. Brain 
2013;136:1857-1867. 
55. Geber C, Klein T, Azad S, Birklein F, Gierthmuhlen J, Huge V, Lauchart M, Nitzsche D, 
Stengel M, Valet M, Baron R, Maier C, Tolle T and Treede RD. Test-retest and interobserver 
reliability of quantitative sensory testing according to the protocol of the German Research 
Network on Neuropathic Pain (DFNS): A multi-centre study. Pain 2011;152:548-56. 
56. Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, 
Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, 
Chappell AS, Cowan P, Etropolski M, Fillingim RB, Gewandter JS, Katz NP, Kopecky EA, 
Markman JD, Nomikos G, Porter L, Rappaport BA, Rice AS, Scavone JM, Scholz J, Simon LS, 
Smith SM, Tobias J, Tockarshewsky T, Veasley C, Versavel M, Wasan AD, Wen W and Yarnitsky 
D. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. 
Pain 2016;5:5. 
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
57. Gatchel RJ, Peng YB, Peters ML, Fuchs PN and Turk DC. The biopsychosocial approach to 
chronic pain: scientific advances and future directions. Psychological bulletin 2007;133:581-624. 
 
Figure legends 
Figure 1: Averaged QST-profiles in the NDSD group (left column) and in the pain-only group (right 
column). Increases in sensory threshold are related to loss of sensory function, and are shown with negative 
z-scores±SD. *Significant after correction for multiple comparisons. Significant post-hoc comparisons 
between NDSD group and pain-only group are indicated with 
§
. 
§
p<0.05 after correction for multiple 
comparisons, ipsilateral side NDSD group compared to ipsilateral side of pain-only group. 
§§
p<0.05, after 
correction for multiple comparisons, differences between NDSD group and pain-only group on both ipsi- and 
contralateral sides. The grey bar indicates the normal range based on literature data from healthy controls 
[10].   
CDT: cold detection threshold. WDT: warm detection threshold. CPT: cold pain threshold. HPT: heat pain 
threshold. MDT: mechanical detection threshold. MPT: mechanical pain threshold.  VDT: vibration detection 
threshold. PPT: pressure pain threshold. Contralateral and ipsilateral is refered to the side of pronounced pain 
in the NDSD group and in the pain-only group to randomized side. 
Figure 2: Correlations between pain intensity and sensory thresholds on ipsilateral sides for CDT, WDT, 
MDT, VDT and PPT. *significant after correction for multiple comparisons. In the scatterplot the x-axis 
corresponds to the z-transformed sensory threshold, the y-axis pain intensity (von Korff). Pain intensity is 
associated with a loss of function for several parameters and a gain of function for pressure pain (PPT).  
Figure 3:  Correlations between anxiety and sensory thresholds on ipsilateral sides. *significant after 
correction for multiple comparisons. In the scatterplot the y-axis corresponds to the z-transformed sensory 
threshold, the x-axis to the HADS-A score. Anxiety is associated with a loss of function. HADS-A: Hospital 
anxiety and depression scale, part anxiety. CDT: cold detection threshold. WDT: warm detection threshold. 
VDT: vibration detection threshold.  
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TABLE 1.  Socio-demographic and pain related data 
  NDSD group 
n=25 
pain–only 
group n=23 
p-value 
Age in years  
Sex female (n)        
42.1±9.9 
17 
43.1±10.5 
15 
0.725 
1.000 
Immigration status:  
                   none 
                   1
st
 generation 
                   2
nd
 generation    
 
6 
19 
0 
 
16 
5 
2 
 
0.010 
Immigration from countries    
                  Central Europe 1 0  0.006 
                  East Europe 0 1  
                  South-western Europe 1 2  
                  South-eastern Europe 17 2  
                  Asia 0 1  
                  Other 0 1  
HADS-anxiety* 11.6±5.0 7.4±3.2 0.003 
SF-12         physical (42.9-56.4)  
                   mental    (43.7-56.1) 
29.8±6.6 
36.9±10.0 
37.1±8.8 
40.9±10.8 
0.004 
0.160 
CPGQ (von Korff):  
                  Mean pain intensity                   
                  Grade  0  
                  Grade 1   
                  Grade 2   
                  Grade 3  
                  Grade 4 
 
74.8 ±14.3 
0 
0 
2 
7 
16 
 
64.5 ±17.7 
2 
1 
6 
6 
8 
  
 
0.038 
0.012 
MPSS:       Stage I   (n): 
                  Stage II  (n): 
                  Stage III (n): 
 0 
4 
21 
 4 
11 
8 
 <0.001 
*Normal ≤ 7. CPGQ: Chronic Pain Grading Questionnaire. HADS: Hospital Anxiety and Depression Scale. 
MPSS: Mainz Pain Staging System. SD: standard deviation. NRS: numeric rating scale 0-10/10. Ordinal 
variables were analysed with the Mann-WhitneyTest  (exact p-values). 
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 TABLE 2. Quantitative sensory testing (QST) in the NDSD group and pain only group 
  ANOVA Post-hoc tests NDSD vs. pain-only group 
Region / 
parameter  
Group Side Group X 
Side 
Ipsilateral Contralateral 
Face           
CDT 0.001 0.010 0.017 <0.001
§
 0.003
§
 
WDT 0.001 0.010 n.s. <0.001
§
 0.001
§
 
CPT n.s. n.s. n.s n.s. n.s. 
HPT n.s. n.s. n.s. n.s. n.s. 
MDT 0.001 0.001 0.013 0.001
§
 0.012 
MPT n.s. n.s. 0.001 n.s. n.s. 
VDT 0.001 0.090 0.037 <0.001
§
 <0.001
§
 
PTT n.s. n.s. n.s. n.s. n.s. 
Hand 
CDT 0.004 0.054 n.s. 0.008 0.007 
WDT 0.085 n.s. n.s. 0.042 n.s. 
CPT n.s. 0.011 n.s. n.s. n.s. 
HPT n.s. n.s. n.s. n.s. n.s. 
MDT 0.017 <0.001 0.013 0.002
§
 n.s. 
MPT 0.017 n.s. 0.048 0.002
§
 n.s. 
VDT 0.001 n.s. 0.037 <0.001
§
 <0.001
§
 
PTT 0.020 n.s. n.s. 0.021 0.053 
Foot 
CDT 0.006 0.043 n.s. 0.009 0.023 
WDT n.s. n.s. n.s. 0.082 n.s. 
CPT n.s. 0.001 0.010 n.s. n.s. 
HPT n.s. 0.001 0.022 n.s. n.s. 
MDT 0.009 0.001 0.001 <0.001
§
 n.s. 
MPT 0.004 n.s. 0.012 <0.001
§
 n.s. 
VDT <0.001 n.s. 0.027 <0.001
§
 <0.001
§
 
PTT 0.012 n.s. 0.083 0.075 0.003
§
 
CDT: cold detection threshold. WDT: warm detection threshold. CPT: cold pain threshold. HPT: heat pain 
threshold. MDT: mechanical detection threshold. MPT: mechanical pain threshold.  VDT: vibration 
detection threshold. PPT: pressure pain threshold.
 §p≤0.003 was considered significant in post-hoc tests. n.s. 
indicates p-values ≥ 0.1 
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